CANS-MCI - Key Persons

In partnership with Dr. Emory Hill, Brian Fogel is the designer and developer of the CANS-MCI, working on the project from its inception until now and currently fills the roles of Screen, Inc. CTO & CEO. He is a graphic designer, UI designer, application developer, animator and multimedia specialist, and has worked for numerous clients, large and small, in the Pacific Northwest. He is a certified mediator and 24-year student of the martial art Aikido.

Job Titles:

• Founder of Screen Inc
• Senior Management

Emory Hill, Founder of Screen Inc., served as CEO from 2000 until 2012. Emory guided the Screen team to a leadership position in CNS Assessments/Testing - with a specialty in computer-directed neuropsychological testing for the purposes of detecting MCI (Alzheimer's) and other dementia- and injury-related cognitive impairments. Early in the company's development, Emory received grants from the NIA and VA to develop new, cutting-edge neuropsychological tests capable of detecting MCI. He is an expert in computer-directed neuropsychological testing for the early detection of MCI and a speaker at scientific conferences, workshops, and Alzheimer's forums. As an advocate of early screening for memory problems, Emory has worked closely with senior centers, social workers, community health centers, geriatric providers, and neurologists over the years. Dr. Hill received his PhD in Clinical Psychology from the State University of New York at Buffalo. Later he completed an Informatics Fellowship at the VA where he studied interface design, multimedia programming, user resistance, and the implementation of automated medical records. A psychometric specialist, Emory ran a group private practice and he was an Assistant Professor of Psychology at SUNY, Brockport, NY. The exceptional user-friendliness of the CANS-MCI has been widely recognized and attributed to his specialty training along with several years of research and development specific to the dimension of usability.

Job Titles:

• COO at Screen, Inc
• Deceased

After 2 years as the COO at Screen, Inc., Mr. Costa assumed the top leadership position in 2012. Sadly, Mr. Costa died on July 22, 2022. He is dearly missed and his duties are being temporarily carried out by the current senior technical and clinical employees. Questions about billing are now directed to Brian Fogel, Technical Director. Fortunately, Frank was the kind of leader who anticipated problems and automated as many business operations as possible. This allows us to continue operations as usual. Mr. Costa brought over thirty years of experience as a high level executive in dynamic technology companies, ranging in size from privately held start-ups to publicly held multinational organizations. He demonstrated an impressive track record of success as CEO of publicly traded companies, as well as VP of Marketing, Group Vice President and General Manager of numerous successful organizations. Throughout his career Mr. Costa founded companies, obtained financing from variety of sources both private and public, managed both small as well as multinational operations for growth and profitability, and expanded the businesses through successful mergers and acquisitions.

He received his Ph.D. in Life-Span Developmental Psychology from The University of Akron in Ohio and completed postdoctoral fellowships at the Duke University Medical Center in Neuropsychology and Geriatric Evaluation & Treatment. Throughout his distinguished career, Dr. Schmitt has developed and evaluated statistical methodologies for the early detection of Alzheimer's disease-and for the statistical assessment of various treatment interventions.

Michael originally joined Screen in 2010 and tenured until 2013, helping to launch its initial test offering to clinicians who need a better cognitive test. Under Michael's leadership Screen grew 600% and served clients around the world. As of January 2023 he has returned to reprise his role as the VP of Sales and Marketing. Michael has a strong background working with medical startups and other venture capital backed entities in medical technology. He has his Masters in Education from Northwest University. He has a passion for helping others and is involved in a few philanthropic organizations that assist with the high risk, near-homeless families in the Seattle area.

Shannon joined the Screen Inc. team in 2021 in the Director of Clinical Services role. She received her Bachelor of Science in Nursing degree from Palm Beach Atlantic University and began her career in emergency medicine at Duke University. She also gained several years of experience in the interventional procedure suite. Shannon has a Master of Science in Nursing degree from Indiana Wesleyan University and is board certified in family practice. Her experience in data review, academic content development, and specialty care bring a unique skill set to her role. Additionally, she has received several awards for excellence in nursing and leadership. She is a member of the American Association of Nurse Practitioners and has been inducted into the Sigma Theta Tau International Honor Society of Nursing. While seeing patients in the clinical setting, Shannon saw first-hand the effects that cognitive impairments can have on the individual and family. These effects range from physical safety concerns to stress on the support system for the patient. These experiences contributed to her passion for detecting cognitive impairment earlier to improve medical care, family support, and patient safety.

Job Titles:

• Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine

Soo Borson is a Professor of Psychiatry and Behavioral Sciences at the University of Washington School of Medicine and is the Director of the University of Washington Medical Center's Memory Disorders Clinic. Dr. Borson is a graduate of Stanford University's School of Medicine. She completed her residency at the University of Washington's Psychiatric and Geropsychiatric Programs and is board certified from the American Board of Psychiatry and Neurology (subspecialties in Geriatric Psychiatry and General Psychiatry). Soo is a Fellow of the Hedwig van Ameringen Executive Leadership Program in Academic Medicine. Soo's clinical interests focus on diagnosis and treatment of dementias. Her research activities bridge clinical neuroscience and health services-focusing principally on improving early diagnosis and comprehensive care for cognitive disorders of late life. A prolific publisher (hundreds of articles) and lecturer on depression and dementia (grand rounds, symposia and continuing education)-and a core investigator in the Alzheimer's Disease Research Center-Soo has provided leadership and service to many organizations throughout her career, including serving as past Chair of the NIMH Mental Disorders of Aging/Initial Review Group, past President of the American Association for Geriatric Psychiatry, and past President of the Geriatric Mental Health Foundation. She currently serves as senior editorial advisor to the American Journal of Geriatric Psychiatry and is Associate Editor (Neuropsychiatry) of the Journal of the American Geriatrics Society.